Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13720)
All Articles published online
|
Publishing Process of This Article
|
Jan 18, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Bertino G, Ardiri A, Proiti M, Rigano G, Frazzetto E, Demma S, Ruggeri MI, Scuderi L, Malaguarnera G, Bertino N, Rapisarda V, Di Carlo I, Toro A, Salomone F, Malaguarnera M, Bertino E, Malaguarnera M. Chronic hepatitis C: This and the new era of treatment. World J Hepatol 2016; 8(2): 92-106 [PMID: 26807205 DOI: 10.4254/wjh.v8.i2.92] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i2/92.htm |
| Number | Citing Articles |
| 1 |
Zijian Qin, Maolin Wang, Aixia Yan. QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM). Bioorganic & Medicinal Chemistry Letters 2017; 27(13): 2931 doi: 10.1016/j.bmcl.2017.05.001
|
| 2 |
Malik Sallam, Rawan Batarseh, Anas Natsheh, Jumana Abbadi, Esraa Al-Fraihat, Alaa’ Yaseen, Doaa Kaddomi, Nadia Khamees, Azmi Mahafzah, Gülşen Özkaya Şahin. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman. BMC Infectious Diseases 2020; 20(1) doi: 10.1186/s12879-019-4735-3
|
| 3 |
Molham Abdulsamad, Ariyo Ihimoyan. Viekira Pak Induced Fatal Lactic Acidosis: A Case Report of an Unusual Side Effect. Case Reports in Hepatology 2016; 2016: 1 doi: 10.1155/2016/8627139
|
| 4 |
Angel Hernández-Bartolomé, Rosario López-Rodríguez, María Jesús Borque, Leticia González-Moreno, Yolanda Real-Martínez, Luisa García-Buey, Ricardo Moreno-Otero, Paloma Sanz-Cameno. Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. World Journal of Gastroenterology 2016; 22(44): 9744-9751 doi: 10.3748/wjg.v22.i44.9744
|
| 5 |
Amanda Chaney. Cuidar de pacientes con infección crónica por virus de la hepatitis C. Nursing (Ed. española) 2019; 36(6): 32 doi: 10.1016/j.nursi.2019.11.008
|
| 6 |
Giulia Malaguarnera, Gaetano Bertino, Giuseppe Chisari, Massimo Motta, Michele Vecchio, Marco Vacante, Filippo Caraci, Carmela Greco, Filippo Drago, Giuseppe Nunnari, Michele Malaguarnera. Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability. BMC Psychiatry 2016; 16(1) doi: 10.1186/s12888-016-1115-z
|
| 7 |
Giulia Malaguarnera, Gaetano Bertino, Carmela Greco, Caterina Gagliano, Massimo Motta, Giuseppe Chisari, Venerando Rapisarda, Giuseppe Nunnari, Michele Vecchio, Filippo Drago, Michele Malaguarnera. Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study. Translational Medicine Communications 2017; 2(1) doi: 10.1186/s41231-016-0010-4
|
| 8 |
S Amele, L Peters, M Sluzhynska, A Yakovlev, A Scherrer, P Domingo, J Gerstoft, JP Viard, M Gisinger, R Flisiak, S Bhaghani, M Ristola, C Leen, E Jablonowska, G Wandeler, H Stellbrink, K Falconer, A D'Arminio Monforte, A Horban, JK Rockstroh, JD Lundgren, A Mocroft. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus‐coinfected individuals in EuroSIDA. HIV Medicine 2019; 20(4): 264 doi: 10.1111/hiv.12711
|
| 9 |
Tilo Freiwald, Meryl Waldman, Behdad Afzali. Clinical Immunology. 2023; : 866 doi: 10.1016/B978-0-7020-8165-1.00068-X
|
| 10 |
Gaetano Bertino, Giulia Malaguarnera, Evelise Frazzetto, Alice Sciuto, Gaetano Inserra, Guido Nicola Zanghì, Michele Malaguarnera. Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions. World Journal of Hepatology 2018; 10(6): 448-451 doi: 10.4254/wjh.v10.i6.448
|
| 11 |
Ángel Hernández‐Bartolomé, Rosario López‐Rodríguez, Luisa García‐Buey, Samuel Martín‐Vílchez, Yolanda Rodríguez‐Muñoz, María Jesús Borque, Leticia González‐Moreno, Yolanda Real‐Martínez, Jorge Mendoza‐Ridruejo, Elena Martín‐Pérez, Ricardo Moreno‐Otero, Paloma Sanz‐Cameno. Intrahepatic angiopoietin‐2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems. Liver International 2017; 37(8): 1148 doi: 10.1111/liv.13352
|
| 12 |
Siqi Peng, Huizhen Wang, Zhengtao Wang, Qingzhong Wang. Progression of Antiviral Agents Targeting Viral Polymerases. Molecules 2022; 27(21): 7370 doi: 10.3390/molecules27217370
|
| 13 |
Venerando Rapisarda, Carla Loreto, Michele Malaguarnera, Annalisa Ardiri, Maria Proiti, Giuseppe Rigano, Evelise Frazzetto, Maria Irene Ruggeri, Giulia Malaguarnera, Nicoletta Bertino, Mariano Malaguarnera, Vito Emanuele Catania, Isidoro Di Carlo, Adriana Toro, Emanuele Bertino, Dario Mangano, Gaetano Bertino. Hepatocellular carcinoma and the risk of occupational exposure. World Journal of Hepatology 2016; 8(13): 573-590 doi: 10.4254/wjh.v8.i13.573
|
| 14 |
Almas Shamaila Mohammed, Aniket Balapure, Mahammad Nanne Khaja, Ramakrishnan Ganesan, Jayati Ray Dutta. Naked-eye colorimetric detection of HCV RNA mediated by a 5′ UTR-targeted antisense oligonucleotide and plasmonic gold nanoparticles. The Analyst 2021; 146(5): 1569 doi: 10.1039/D0AN02481C
|
| 15 |
Dagmara Przekop, Jakub Klapaczynski, Agnieszka Grytczuk, Ewa Gruszewska, Andrzej Gietka, Anatol Panasiuk, Slawomir Golaszewski, Bogdan Cylwik, Lech Chrostek. Non-Invasive Indirect Markers of Liver Fibrosis after Interferon-Free Treatment for Hepatitis C. Journal of Clinical Medicine 2021; 10(17): 3951 doi: 10.3390/jcm10173951
|
| 16 |
Serap Beldar, Malathy Sony Subramanian Manimekalai, Nam-Joon Cho, Kwanghee Baek, Gerhard Grüber, Ho Sup Yoon. Self-association and conformational variation of NS5A domain 1 of hepatitis C virus.
Journal of General Virology
2018; 99(2): 194 doi: 10.1099/jgv.0.001000
|
| 17 |
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospects. European Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
|
| 18 |
Chun-Ming Hong, Chen-Hua Liu, Tung-Hung Su, Hung-Chih Yang, Pei-Jer Chen, Yu-Wen Chen, Jia-Horng Kao, Chun-Jen Liu. Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data. Journal of Microbiology, Immunology and Infection 2020; 53(4): 569 doi: 10.1016/j.jmii.2018.09.005
|
| 19 |
Salamata Diallo, Mariéme Polele Fall, Marie Louise Bassène, Mamadou Ngoné Gueye, Mame Aissé Thioubou, Cheikh Ahmadou Bamba Cissé, Alioune Badara Fall, Abdoul Aziz Atteib Fall, Alsine Yauck. Hepatitis C: Epidemiological, Clinical and Therapeutic Aspects in Dakar (Senegal). Open Journal of Gastroenterology 2022; 12(04): 98 doi: 10.4236/ojgas.2022.124010
|
| 20 |
Helena H.L. Borba, Ursula Rochau, Astrid Wiens, Gaby Sroczynski, Uwe Siebert, Vinicius L. Ferreira, Eimy Minowa, Roberto Pontarolo. Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective. Value in Health Regional Issues 2019; 20: 95 doi: 10.1016/j.vhri.2019.02.005
|
| 21 |
Sern Wei Yeoh, Alex C. N. Holmes, Michael M. Saling, Ian P. Everall, Amanda J. Nicoll. Depression, fatigue and neurocognitive deficits in chronic hepatitis C. Hepatology International 2018; 12(4): 294 doi: 10.1007/s12072-018-9879-5
|
| 22 |
V. E. Ekushov, A. V. Totmenin, L. G. Gotfrid, M. R. Halikov, V.-V. V. Minikhanova, S. E. Skudarnov, T. S. Ostapova, N. M. Gashnikova. Genetic diversity of hepatitis C virus and the prevalence of resistance mutations to NS5A inhibitors in the Krasnoyarsk region. South of Russia: ecology, development 2024; 19(1): 47 doi: 10.18470/1992-1098-2024-1-4
|
| 23 |
Waleed A. Ismail, Ayman E. Yousef. Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis. European Journal of Gastroenterology & Hepatology 2019; 31(8): 1025 doi: 10.1097/MEG.0000000000001370
|
| 24 |
D. E. Valutite, A. V. Semenov, Yu. V. Ostankova, K. V. Kozlov, A. G. Borisov, V. D. Nazarov, A. A. Totolian. Detection of drug resistance mutations of hepatitis C virus in patients with failure of the treatment with direct acting antivirals. Journal of microbiology, epidemiology and immunobiology 2021; 98(1): 18 doi: 10.36233/0372-9311-47
|
| 25 |
Arun Jose, Shimul A. Shah, Nadeem Anwar, Courtney R. Jones, Francis X. McCormack, Kenneth E. Sherman, Jean M. Elwing. Predictors of outcomes following liver transplant in hepatopulmonary syndrome: An OPTN database analysis. Respiratory Medicine 2021; 190: 106683 doi: 10.1016/j.rmed.2021.106683
|
| 26 |
Jeffrey L. Roberson, Virginia L. Kan. Hepatitis C Virus Continuum of Care in the Interferon and Direct-Acting Agent Eras Among HIV-Coinfected Patients. AIDS Research and Human Retroviruses 2017; 33(5): 405 doi: 10.1089/aid.2016.0170
|
| 27 |
Diana Valutite, Yulia Ostankova, Alexandr Semenov, Liudmila Lyalina, Areg Totolian. Distribution of Primary Resistance Mutations in Saint Petersburg in Patients with Chronic Hepatitis C. Diagnostics 2022; 12(5): 1054 doi: 10.3390/diagnostics12051054
|
| 28 |
J. Bagg, K. Roy, L. Hopps, I. Black, D. Croser, C. O'Halloran, F. Ncube. No longer 'written off' – times have changed for the BBV-infected dental professional. British Dental Journal 2017; 222(1): 47 doi: 10.1038/sj.bdj.2017.36
|
| 29 |
Florian Bayer, Benoît Audry, Corinne Antoine, Carine Jasseron, Camille Legeai, Olivier Bastien, Christian Jacquelinet. Removing administrative boundaries using a gravity model for a national liver allocation system. American Journal of Transplantation 2021; 21(3): 1080 doi: 10.1111/ajt.16214
|
| 30 |
Ertugrul Erken, Orcun Altunoren, Ozkan Gungor. Poor management of hepatitis C infection will cause serious issues for patients with advanced chronic kidney disease. Journal of Evidence-Based Medicine 2021; 14(2): 87 doi: 10.1111/jebm.12433
|
| 31 |
R. Ragusa, G. Bertino, A. Bruno, E. Frazzetto, F. Cicciu, G. Giorgianni, L. Lupo. Evaluation of health status in patients with hepatitis c treated with and without interferon. Health and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0842-x
|
| 32 |
Chun-Ming Hong, Chun-Jen Liu, Shiou-Hwei Yeh, Pei-Jer Chen. Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response. Journal of the Formosan Medical Association 2017; 116(4): 295 doi: 10.1016/j.jfma.2016.11.014
|
| 33 |
Tessa M Nápoles, Abigail W Batchelder, Ada Lin, Lissa Moran, Mallory O Johnson, Martha Shumway, Anne F Luetkemeyer, Marion G Peters, Kellene V Eagen, Elise D Riley. HCV treatment barriers among HIV/HCV co-infected patients in the US: a qualitative study to understand low uptake among marginalized populations in the DAA era. Journal of Public Health 2019; 41(4): e283 doi: 10.1093/pubmed/fdz045
|
| 34 |
Stefania Notari, Massimo Tempestilli, Gabriele Fabbri, Raffaella Libertone, Andrea Antinori, Adriana Ammassari, Chiara Agrati. UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients. Journal of Chromatography B 2018; 1073: 183 doi: 10.1016/j.jchromb.2017.12.018
|
| 35 |
Naser F. Al-Tannak, Ahmed Hemdan, Maya S. Eissa. Development of a Robust UPLC Method for Simultaneous Determination of a Novel Combination of Sofosbuvir and Daclatasvir in Human Plasma: Clinical Application to Therapeutic Drug Monitoring. International Journal of Analytical Chemistry 2018; 2018: 1 doi: 10.1155/2018/6535816
|
| 36 |
Jonathan Schmelzer, Ellen Dugan, Sarah Blach, Samantha Coleman, Zongzhen Cai, Mindi DePaola, Chris Estes, Ivane Gamkrelidze, Kathryn Jerabek, Siyi Ma, Shauna Montoya, Devin Razavi-Shearer, Kathryn Razavi-Shearer, Sarah Robbins-Scott, Homie Razavi, Manal Hamdy El Sayed. Global prevalence of hepatitis C virus in children in 2018: a modelling study. The Lancet Gastroenterology & Hepatology 2020; 5(4): 374 doi: 10.1016/S2468-1253(19)30385-1
|
| 37 |
Mariantonietta Di Stefano, Mona H. Ismail, Thomas Leitner, Giuseppina Faleo, Marwan Jabr Alwazzeh, Jean Lutamyo Mbisa, Josè Ramon Fiore, Teresa Antonia Santantonio. A novel candidate hepatitis C virus genotype 4 subtype identified by next generation sequencing full-genome characterization in a patient from Saudi Arabia. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1285367
|
| 38 |
D. E. Reingardt, Yu. V. Ostankova, L. V. Lyalina, E. V. Anufrieva, A. V. Semenov, Areg A. Totolian. Distribution of hepatitis С virus drug resistance mutations among patients with recurrence of the disease during therapy with direct antiviral drugs. HIV Infection and Immunosuppressive Disorders 2024; 15(4): 86 doi: 10.22328/2077-9828-2023-15-4-86-93
|
| 39 |
Amanda Chaney. Caring for patients with chronic hepatitis C infection. Nursing 2019; 49(3): 36 doi: 10.1097/01.NURSE.0000553271.39804.a4
|
| 40 |
Jeffrey L. Roberson, Alicia M. Lagasca, Virginia L. Kan. Comparison of the Hepatitis C Continua of Care Between Hepatitis C Virus/HIV Coinfected and Hepatitis C Virus Mono-Infected Patients in Two Treatment Eras During 2008–2015. AIDS Research and Human Retroviruses 2018; 34(2): 148 doi: 10.1089/aid.2017.0092
|
| 41 |
Marleen H. M. Hessel, Adam F. Cohen, Robert Rissmann. Sofosbuvir and daclatasvir. British Journal of Clinical Pharmacology 2016; 82(3): 878 doi: 10.1111/bcp.13011
|
| 42 |
Rosario López-Rodríguez, Ángel Hernández-Bartolomé, María Jesús Borque, Yolanda Rodríguez-Muñoz, Samuel Martín-Vílchez, Luisa García-Buey, Leticia González-Moreno, Yolanda Real-Martínez, Paloma Muñoz de Rueda, Javier Salmerón, José Ramón Vidal-Castiñeira, Carlos López-Larrea, Luis Rodrigo, Ricardo Moreno-Otero, Paloma Sanz-Cameno, Matias A. Avila. Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C. PLOS ONE 2017; 12(7): e0180927 doi: 10.1371/journal.pone.0180927
|
| 43 |
Nahed Mohammed Hawsawi, Tamer Saber, Hussein M. Salama, Walaa S. Fouad, Howaida M. Hagag, Hayaa M. Alhuthali, Emad M. Eed, Taisir Saber, Khadiga A. Ismail, Hesham H. Al Qurashi, Samir Altowairqi, Mohmmad Samaha, Dalia El-Hossary. Genotypes of Hepatitis C Virus and Efficacy of Direct-Acting Antiviral Drugs among Chronic Hepatitis C Patients in a Tertiary Care Hospital. Tropical Medicine and Infectious Disease 2023; 8(2): 92 doi: 10.3390/tropicalmed8020092
|
| 44 |
V A Malov, E A Ubeeva, I P Ubeeva, S M Nikolaev, K T Umbetova. Treatment of chronic viral hepatitis C with direct acting antiviral agent: review. Terapevticheskii arkhiv 2019; 91(11): 86 doi: 10.26442/00403660.2019.11.000307
|
| 45 |
Ricard Masia, Joseph Misdraji. Diagnostic Pathology of Infectious Disease. 2018; : 272 doi: 10.1016/B978-0-323-44585-6.00011-4
|
| 46 |
Rosario Gravier-Hernández, Lizette Gil-del Valle, Lindunka Valdes-Alonso, Nadiecha Hernández-Ayala, Yusimit Bermúdez-Alfonso, Daymé Hernández-Requejo, Teresa Rosell-Guerra, Maria C. Hernández-González-Abreu. Oxidative stress in hepatitis C virus–human immunodeficiency virus co-infected patients. Annals of Hepatology 2020; 19(1): 92 doi: 10.1016/j.aohep.2019.05.009
|
| 47 |
Manal El‐Hamamsy, Iman Fawzy Montasser, Azza El‐Sayed Mansy, Dina Ezzeldin Nabet, Mahmoud El‐Meteini. Effect of cyclosporine A versus tacrolimus on the response to antiviral therapy after hepatitis C genotype‐4 recurrence post–liver transplantation: A prospective cohort trial. Journal of Clinical Pharmacy and Therapeutics 2019; 44(3): 447 doi: 10.1111/jcpt.12807
|
| 48 |
Juliana Cristina Santiago Bastos, Marina Aiello Padilla, Leonardo Cardia Caserta, Noelle Miotto, Aline Gonzalez Vigani, Clarice Weis Arns. Hepatitis C virus: Promising discoveries and new treatments. World Journal of Gastroenterology 2016; 22(28): 6393-6401 doi: 10.3748/wjg.v22.i28.6393
|
| 49 |
Iman Ibrahim Salama, Hala M Raslan, Ghada A Abdel-Latif, Somaia I Salama, Samia M Sami, Fatma A Shaaban, Aida M Abdelmohsen, Walaa A Fouad. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection. World Journal of Hepatology 2022; 14(6): 1053-1073 doi: 10.4254/wjh.v14.i6.1053
|
| 50 |
Stefania Bartoloni, Stefano Leone, Filippo Acconcia. Unexpected Impact of a Hepatitis C Virus Inhibitor on 17β-Estradiol Signaling in Breast Cancer. International Journal of Molecular Sciences 2020; 21(10): 3418 doi: 10.3390/ijms21103418
|
| 51 |
Manuela Pennisi, Gaetano Bertino, Caterina Gagliano, Michele Malaguarnera, Rita Bella, Antonio Borzì, Roberto Madeddu, Filippo Drago, Giulia Malaguarnera. Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance. Nutrients 2017; 9(8): 897 doi: 10.3390/nu9080897
|
| 52 |
Ossama Ashraf Ahmed, Eslam Safwat, Mohamed Omar Khalifa, Ahmed I. Elshafie, Mohamed Hassan Ahmed Fouad, Mohamed Magdy Salama, Gina Gamal Naguib, Mohamed Mahmoud Eltabbakh, Ahmed Fouad Sherief, Sherief Abd-Elsalam. Sofosbuvir Plus Daclatasvir in Treatment of Chronic Hepatitis C Genotype 4 Infection in a Cohort of Egyptian Patients: An Experiment the Size of Egyptian Village. International Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/9616234
|
| 53 |
HanyMohammed Ibrahim, FatenRoshdy Abdel-Ghaffar, AhmedBahgat Zied, SamehaHusni El-Ghareeb. Assessment of the sofosbuvir + daclatasvir (±) ribavirin treatment and the prognostic efficacy of interferon-gamma induced protein 10, macrophage inflammatory-1-beta, and C-reactive protein in Hepatitis C Egyptian patients' therapy outcome. Biomedical and Biotechnology Research Journal (BBRJ) 2022; 6(1): 109 doi: 10.4103/bbrj.bbrj_209_21
|
| 54 |
Eldar Abdurakhmanov, Sara Øie Solbak, U. Danielson. Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) Polymerase. Viruses 2017; 9(6): 151 doi: 10.3390/v9060151
|
| 55 |
|
| 56 |
Amanda Mocroft, Jens D Lundgren, Juergen K Rockstroh, Inka Aho, Gilles Wandeler, Lars Nielsen, Simon Edwards, Jean-Paul Viard, Karine Lacombe, Gerd Fätkenheuer, Giovanni Guaraldi, Montserrat Laguno, Josep Llibre, Hila Elinav, Leo Flamholc, Martin Gisinger, Dzmitry Paduta, Irina Khromova, David Jilich, Blazej Rozplochowski, Cristiana Oprea, Lars Peters, A Harxhi, M Losso, M Kundro, B Schmied, R Zangerle, I Karpov, A Vassilenko, D Paduto, N Clumeck, S De Wit, M Delforge, E Florence, L Vandekerckhove, V Hadziosmanovic, J Begovac, L Machala, D Jilich, D Sedlacek, G Kronborg, T Benfield, J Gerstoft, T Katzenstein, C Pedersen, I S Johansen, L Ostergaard, L Wiese, N F Moller, K Zilmer, I Aho, J-P Viard, P-M Girard, C Pradier, E Fontas, C Duvivier, J Rockstroh, G Behrens, O Degen, H J Stellbrink, J Bogner, G Fätkenheuer, N Chkhartishvili, H Sambatakou, G Adamis, N Paissios, J Szlávik, M Gottfredsson, C Kelly, L Tau, D Turner, M Burke, E Shahar, G Hassoun, H Elinav, M Haouzi, D Elbirt, A D’arminio Monforte, R Esposito, I Mazeu, C Mussini, F Mazzotta, A Gabbuti, A Lazzarin, A Castagna, N Gianotti, M Galli, A Ridolfo, V Uzdaviniene, R Matulionyte, T Staub, R Hemmer, S Dragas, M Stevanovic, P Reiss, J Trajanovska, D H Reikvam, A Maeland, J Bruun, B Knysz, J Gasiorowski, M Inglot, E Bakowska, R Flisiak, A Grzeszczuk, M Parczewski, K Maciejewska, B Aksak-Was, M Beniowski, E Mularska, E Jablonowska, J Kamerys, K Wojcik, I Mozer-Lisewska, B Rozplochowski, A Zagalo, K Mansinho, F Maltez, C Oprea, A Yakovlev, I Khromova, E Kuzovatova, E Borodulina, E Vdoushkina, J Ranin, J Tomazic, J M Miro, M Laguno, E Martinez, F Garcia, J L Blanco, M Martinez-Rebollar, J Mallolas, P Callau, J Rojas, A Inciarta, S Moreno, B Clotet, A Jou, R Paredes, J Puig, J M Llibre, J R Santos, P Domingo, M Gutierrez, G Mateo, M A Sambeat, J M Laporte, K Falconer, A Thalme, A Sonnerborg, C J Treutiger, L Flamholc, A Scherrer, R Weber, M Cavassini, A Calmy, H Furrer, M Battegay, P Schmid, A Kuznetsova, J Mikhalik, M Sluzhynska, A Milinkovic, A M Johnson, E Simons, S Edwards, A Phillips, M A Johnson, A Mocroft, A Winston, A Clarke, C Leen, I Karpov, M Losso, J Lundgren, J Rockstroh, I Aho, L D Rasmussen, V Svedhem, G Wandeler, C Pradier, N Chkhartishvili, R Matulionyte, C Oprea, J D Kowalska, J Begovac, J M Miró, G Guaraldi, R Paredes, G Wandeler, R Paredes, O Kirk, L Peters, A Bojesen, D Raben, E V Hansen, D Kristensen, J F Larsen, A H Fischer, A Mocroft, A Phillips, A Cozzi-Lepri, S Amele, A Pelchen-Matthews, A Roen. Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons. Open Forum Infectious Diseases 2020; 7(12) doi: 10.1093/ofid/ofaa470
|
| 57 |
Meryl Waldman, Howard A. Austin, James E. Balow. Clinical Immunology. 2019; : 917 doi: 10.1016/B978-0-7020-6896-6.00068-5
|
| 58 |
Dilruba Garashova, İlker İnanç Balkan, Reşat Özaras, Mert Ahmet Kuşkucu, Ayşenur Özdil, Khalis Mustafayev, Sibel Yıldız Kaya, Rıdvan Karaali, Bilgül Mete, Gökhan Aygün, Neşe Saltoğlu, Ömer Fehmi Tabak. Early Viral Kinetics in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals. Viral Hepatitis Journal 2023; 29(3): 101 doi: 10.4274/vhd.galenos.2023.2023-12-1
|
| 59 |
Dana Busschots, Cécile Kremer, Özgür M. Koc, Leen Heyens, Rob Bielen, Ludwig Apers, Eric Florence, Peter Messiaen, Kristel Van Laethem, Eric Van Wijngaerden, Frederik Nevens, Niel Hens, Geert Robaeys. The hepatitis C cascade of care in the Belgian HIV population: One step closer to elimination. International Journal of Infectious Diseases 2021; 105: 217 doi: 10.1016/j.ijid.2021.02.068
|
| 60 |
Sebastián Marciano, Leila Haddad, Fernando Plazzotta, Ezequiel Mauro, Sergio Terraza, Sanjeev Arora, Karla Thornton, Beatriz Ríos, Carlos García Dans, Natalia Ratusnu, Liliana Calanni, José Allevato, María Ester Sirotinsky, Marcos Pedrosa, Adrián Gadano. Implementation of the ECHO® telementoring model for the treatment of patients with hepatitis C. Journal of Medical Virology 2017; 89(4): 660 doi: 10.1002/jmv.24668
|
| 61 |
Federico Salomone, Maurizio Catania, Arturo Montineri, Gaetano Bertino, Justyna Godos, Leonardo Rizzo, Giovanni Magrì, Giovanni Li Volti. Hepatitis C virus eradication by direct antiviral agents improves glucose tolerance and reduces post‐load insulin resistance in nondiabetic patients with genotype 1. Liver International 2018; 38(7): 1206 doi: 10.1111/liv.13669
|
| 62 |
Vito Emanuele Catania, Giulia Malaguarnera, Giorgia Fiorenza, Eleonora Margherita Chisari, Anna Rita Lipari, Valentino Gallina, Manuela Pennisi, Giuseppe Lanza, Michele Malaguarnera. Hepatitis C Virus Infection Increases Fatigue in Health Care Workers. Diseases 2020; 8(4): 37 doi: 10.3390/diseases8040037
|
| 63 |
Yuqian Yan, Ning Liang, Shibing Liang, Yuxin Sun, Nicola Robinson, Jianping Liu. Evaluation of outcomes reported in randomized controlled trials for herbal remedies for adults with chronic hepatitis C. Journal of Traditional Chinese Medical Sciences 2019; 6(2): 115 doi: 10.1016/j.jtcms.2019.03.002
|
| 64 |
Amanda Mocroft, Lene Ryom, Cristiana Oprea, Qiuju Li, Andri Rauch, Christoph Boesecke, Vilma Uzdaviniene, Dalibor Sedlacek, Josep M. Llibre, Karine Lacombe, Lars N. Nielsen, Eric Florence, Inka Aho, Nikoloz Chkhartishvili, János Szlavik, Gordana Dragovic, Clifford Leen, Helen Sambatakou, Therese Staub, Montse Laguno, Hila Elinav, Janez Tomažič, Lars Peters. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons. AIDS 2020; 34(10): 1485 doi: 10.1097/QAD.0000000000002570
|